MOSCOW (MRC) -- Tokyo- Mitsui Chemicals said it has signed a licensing agreement with Kemira giving Kemira "geographical exclusivity" for the production of acrylamide (AAM) using Mitsui’s proprietary bio-process technology, said Apic-online.
Mitsui noted that its AAM manufacturing technology, which uses bio-catalysts, has been "highly evaluated for its stability in producing high-quality products, when compared with existing copper catalyst chemical processes, and its low burden on the environment."
Separately, Kemira said it has completed a two-year, multi-million euro expansion of its North American polymer production facilities, and added that the agreement with Mitsui will strengthen its polymer product line globally. The expansion resulted in a 60% capacity increase.
As MRC wrote earlier, Mitsui and Dow Chemical have decided to delay construction of a USD1.5 bn sugarcane-to-plastics facility in southeastern Brazil. Dow has chosen to focus on more profitable projects elsewhere, in particular using shale gas reserves in the US as cheap feedstock.
Kemira is a chemical industry group that consists of three main segments. Kemira is headquartered in Helsinki, Finland. Kemira became the world's biggest provider of the pulp and paper chemicals after its acquisition of the pulp and paper chemical operations of Lanxess.
Mitsui Chemicals is a leading manufacturer and supplier of value added specialty chemicals, plastics and materials for the automotive, healthcare, packaging, agricultural, building, and semiconductor and electronics markets. Mitsui Chemicals is a Japanese Chemicals company, a part of the Mitsui conglomerate. The company has a turnover of around 15 billion USD and has business interests in Japan, Europe, China, Southeast Asia and the USA. The company mainly deals in performance materials, petro and basic chemicals and functional polymeric materials.
MRC